Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

British American Tobacco Industries (NY: BTI )

35.13 USD -0.91 (-2.52%)
Streaming Delayed Price Updated: 3:41 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about British American Tobacco Industries

< Previous 1 2 3 4 5 6 7 Next >
NetworkNewsAudio – TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Capitalizes on Growing Demand for Smoking Alternatives with Nicotine-Free, Tobacco-Free Cigarette
From InvestorBrandNetwork
Beyond Tobacco: TAAT Innovation Delivers New Smoking Alternative
NetworkNewsWire Editorial Coverage 
From PR Newswire
Beyond Tobacco: TAAT Innovation Delivers New Smoking Alternative
From InvestorBrandNetwork
Lexaria Bioscience Advances Antiviral Research Initiative Using DehydraTECH™
Tags Living Pharmaceuticals & Biotech Health & Medicine
From AB Newswire
NetworkNewsAudio – Kaival Brands Innovations Group Inc. (KAVL) to Develop Smoking Cessation Products Using Purified, Synthetic Nicotine
From InvestorBrandNetwork
Desperate Need Fuels New Products, Programs in Smoking Cessation Space
From InvestorBrandNetwork
Desperate Need Fuels New Products, Programs in Smoking Cessation Space
FN Media Group Presents NetworkNewsWire Market Commentary 
From PR Newswire
Vaping Emerges from a Cloud
From InvestorBrandNetwork
Vaping Emerges from a Cloud
NetworkNewsWire Editorial Coverage 
From PR Newswire
Hemp and CBD Arise as Alternatives to the Tobacco Industry
FinancialBuzz.com News Commentary 
From PR Newswire
Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending May 31, 2020
BIOASIS TECHNOLOGIES INC. (TSXV:BTI.V; OTCQB:BIOAF), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across... 
From Business Wire News Releases
CBD Offers Cigarette Smokers a New Way Out
FinancialBuzz.com News Commentary 
From PR Newswire
Vape-Related Deaths Turn Smokers Towards Alternative Quit Smoking Aids
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Vape-related Deaths Turn Smokers Towards Alternative Quit Smoking Aids
FN Media Group Presents Microsmallcap.com Market Commentary 
From PR Newswire
Bioasis Announces Stock Option Grants
BIOASIS TECHNOLOGIES INC. (TSXV:BTI.V; OTCQB:BIOAF), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across... 
From Business Wire News Releases
New Innovative Brands Look to Disrupt Big Tobacco with Better-For-You Alternatives
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
New Innovative Brands Look to Disrupt big Tobacco With Better-for-you Alternatives
FN Media Group Presents Microsmallcap.com Market Commentary 
From PR Newswire
CBD-Derived Products May Provide Consumers an Alternative to Tobacco
FinancialBuzz.com News Commentary 
From PR Newswire
Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A
BIOASIS TECHNOLOGIES INC. (TSXV:BTI.V; OTCQB:BIOAF), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the... 
From Business Wire News Releases
Tobacco Users Turn to CBD in Search of an Indicative Substitute
FinancialBuzz.com News Commentary 
From PR Newswire
Bioasis Announces Analyst Coverage Initiated by Edison Group
BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSXV:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the... 
From Business Wire News Releases
Bioasis Technologies Announces the Appointment of Dr. May Orfali to the Position of Consultant Chief Medical Officer
Bioasis Technologies Inc. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across... 
From Business Wire News Releases
Bioasis to Present at the 22nd Annual BIO CEO Investor Conference and the OTC Markets 2020 Virtual Investor Conference
Bioasis Technologies Inc. (OTCQB:BIOAF)(TSX.V:BTI), (the “Company” or “Bioasis”), a biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across... 
From Business Wire News Releases
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2019
Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the... 
From Business Wire News Releases
Bioasis Technologies Inc. Announces Warrant Extension and Repricing
Bioasis Technologies Inc. (“Bioasis” or the “Company”) (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the... 
From Business Wire News Releases
Bioasis to Present at Upcoming Industry Conferences
BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the... 
From Business Wire News Releases
Bioasis Announces Annual General Meeting Results
BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the... 
From Business Wire News Releases
Bioasis Appoints Consultant Chief Medical Officer and Nominates Medical Oncology Advisory Board
BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), ), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics... 
From Business Wire News Releases
Bioasis to Host Annual General Meeting Webcast on December 5, 2019
BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the... 
From Business Wire News Releases
Bioasis Announces Director Resignation
BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account